CRISPR Therapeutics (CRSP) Stock Price & Live Chart

Why CRISPR Therapeutics (CRSP) Matters

CRISPR Therapeutics operates as a biotechnology company focused on developing gene-editing medicines based on CRISPR/Cas9 technology. Its research and development efforts target severe genetic diseases across areas such as hematology, immuno-oncology, regenerative medicine, and in vivo therapies. The company plays a role in the life sciences ecosystem by advancing gene-editing platforms that aim to modify disease-causing genetic material within cells under regulated clinical and manufacturing frameworks.

CRISPR Therapeutics AG is a biotechnology company developing gene-editing therapies using CRISPR/Cas9 technology.